Long-Term Follow-Up Confirms a Sustained Reduction in Deaths from Prostate Cancer with PSA Screening By Ogkologos - November 4, 2025 353 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the ERSPC study Source RELATED ARTICLESMORE FROM AUTHOR Enzalutamide Continues to Provide Substantial Long-Term OS Benefit at 8 Years for Patients with Metastatic Hormone-Sensitive Prostate Cancer Metastatic Breast Cancer: ESMO Living Guideline EMA Recommends Extension of Indications for Datopotamab Deruxtecan MOST POPULAR EMA Recommends Granting a Marketing Authorisation for Nivolumab / Relatlimab August 11, 2022 Identical Twins Get Mirror Cancer Diagnoses Within Three Weeks Of Each... August 15, 2019 ALK Mutations and Amplifications are Independent Predictors of Poorer Survival in... June 24, 2021 Personalised blood test could help predict which lung cancers might return April 1, 2022 Load more HOT NEWS EMA Recommends Granting a Conditional Marketing Authorisation for Adagrasib Following a Re-Examination... Copanlisib Shows Promising Clinical Activity in Select Tumours with PIK3CA Mutation... Young Women with Breast Cancer Often Forgo Hormone Therapy Due to... We’re asking scientists to tackle 9 of the toughest challenges in...
